Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,157,654 papers from all fields of science
Search
Sign In
Create Free Account
Endothelial Growth Factor Receptor
Known as:
Receptor, Endothelial Growth Factors
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Narrower (2)
Vascular Endothelial Growth Factor Receptor
Vascular Endothelial Growth Factor Receptor-1
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
A Flare for the Unexpected: Bone Flare as Response to Tyrosine Kinase Inhibitor Treatment in a Lung Cancer Patient
Charlotte De Bondt
,
A. Snoeckx
,
J. Raskin
Journal of the Belgian Society of Radiology
2020
Corpus ID: 218533522
We report the case of a 72-year-old female never-smoker with stage IV endothelial growth factor receptor (EGFR) mutated lung…
Expand
Review
2016
Review
2016
Afatinib-Induced Acute Fatal Pneumonitis in Metastatic Lung Adenocarcinoma
S. Yoo
,
Jin Ah Ryu
,
+7 authors
Y. Yang
Korean Journal of Family Medicine
2016
Corpus ID: 16941852
Afatinib is an oral tyrosine kinase inhibitor (TKI) that inhibit Endothelial Growth Factor Receptor (EGFR), Human Epidermal…
Expand
Review
2016
Review
2016
Genetic alterations in lung adenocarcinoma with a micropapillary component.
M. Furukawa
,
S. Toyooka
,
+8 authors
S. Miyoshi
Molecular and clinical oncology
2016
Corpus ID: 30492864
Pulmonary adenocarcinoma (PA) with a micropapillary component (PA-MPC) is known as an aggressive subtype of PA. The molecular…
Expand
Review
2013
Review
2013
Incidence and risk of hypomagnesemia in advanced cancer patients treated with cetuximab: A meta-analysis
Peng-Yu Chen
,
Long Wang
,
Hao Li
,
Bing Liu
,
Z. Zou
Oncology Letters
2013
Corpus ID: 17277030
Hypomagnesemia is a serious adverse event for patients treated with cetuximab, an inhibitor of endothelial growth factor receptor…
Expand
2013
2013
Rapid characterization of a novel taspine derivative-HMQ1611 binding to EGFR by a cell membrane chromatography method.
H. Du
,
Nan Lv
,
Sicen Wang
,
Langchong He
Combinatorial chemistry & high throughput…
2013
Corpus ID: 11014949
A new high-expression endothelial growth factor receptor (EGFR) cell membrane chromatography (CMC) method was applied to…
Expand
2012
2012
Diffuse interstitial lung disease linked to vandetanib.
Sylvie Ernesto
,
D. Arpin
,
P. Nesme
,
M. Pérol
Clinical Lung Cancer
2012
Corpus ID: 27898921
2011
2011
Regulation of colon cancer cell proliferation and migration by MD-2 activity
V. Grondin
,
P. Seksik
,
+6 authors
M. Bachelet
Innate Immunity
2011
Corpus ID: 6727024
Evidence suggests that signalling through lipopolysaccharide (LPS) has a significant role in the development of gastrointestinal…
Expand
Review
2011
Review
2011
The efficacy of gemcitabine as salvage treatment in patients with refractory advanced colorectal cancer (CRC): a single institution experience.
M. Saif
,
Kristin Kaley
,
R. Penney
,
S. Hotchkiss
,
K. Syrigos
,
A. Strimpakos
Anticancer Research
2011
Corpus ID: 22159815
OBJECTIVE To assess the efficacy of gemcitabine based chemotherapy in heavily pre-treated patients with advanced colorectal…
Expand
2011
2011
BRAF p.Val600Glu (V600E) somatic mutation is mainly associated with MSS phenotype in metastatic colorectal cancer.
J. Qiu
,
Marion Compagnone
,
+6 authors
S. Olschwang
Cancer Genomics & Proteomics
2011
Corpus ID: 37304950
BACKGROUND Oncogenic activation of EGF-signalling pathway is central to the progression of colorectal cancer. The use of…
Expand
2010
2010
Relation of the Expression of Cyclooxygenase-2 in Colorectal Adenomas and Adenocarcinomas to Angiogenesis and Prognosis
Yoon Dae Han
,
Y. Hong
,
J. Kang
,
Y. Choi
,
Chan Heun Park
Journal of the Korean society of coloproctology
2010
Corpus ID: 436697
Purpose Recent studies have shown that cyclooxygenase (COX)-2 may be involved in tumor growth, invasion and apoptosis in various…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE